2007, Diabetes and Individual - Primary Care Digest

Search:

DAY

WEEK

MONTH

YEAR

Select your country:
Sign up | Log in

2007

Diabetes

Individual

Bisphosphonates for Osteoporosis: Podcast with James Deardorff and Sei Lee

GeriPal

FEBRUARY 17, 2022

When we have a medication with up front harms and downstream benefits, it’s critical that we consider the time to benefit, or how long it will take an individual to benefit from a test or treatment. For individuals with a life expectancy less than the time to benefit, the up front harms outweigh the downstream benefits. .

Clinic

Clinic IT Patients Medical

Navigating Insulin Initiation in Type 2 Diabetes: Unraveling the Sociodemographic and Biological Dynamics [Diabetes and endocrine disease]

Annals of Family Medicine

NOVEMBER 20, 2024

Context: Treatment strategy for type 2 diabetes mellitus(T2DM) often involves stepwise medication intensification, including the consideration of insulin therapy. The decision to initiate insulin is a critical aspect of diabetes management and is influenced by various patient-specific factors. per 13 mmol/mol,95%CI:1.52-1.57)

Diabetes

Diabetes Primary Care Management Individual

Bisphosphonates for Osteoporosis: Podcast with James Deardorff and Sei Lee

Navigating Insulin Initiation in Type 2 Diabetes: Unraveling the Sociodemographic and Biological Dynamics [Diabetes and endocrine disease]

Stay Connected